Patent ID: 7001890

Claim:
A pharmaceutical composition, comprising: (a) at least one polynucleotide of a length of 100 nucleotides or less, wherein the polynucleotide comprises a sequence of a binding site for a transcription factor and which is selected from the group consisting of GATTGCCTGACGTCAGAGAG (SEQ ID NO:8), +0 GGAATGACGTTCCCTGTG (SEQ ID NO:9), +0 AGCTATGACGTTCCAAGG (SEQ ID NO:10), +0 GCTTGATGACTCAGCCGGAA (SEQ ID NO:11), +0 TCGATCGGGGCGGGGCGAGC (SEQ ID NO:12), +0 TGCAGATTGCGCAATCTGCA (SEQ ID NO:13), +0 AGCGGGGGCGAGCGGGGGCG (SEQ ID NO:14), +0 GTCCATTTCCCGTAAATCTT (SEQ ID NO:16), +0 TATGCATATTCCTGTAAGTG (SEQ ID NO:17), +0 CTGATTTCCCCGAAATGATG (SEQ ID NO:19), +0 AGATTTCTAGGAATTCAATC (SEQ ID NO:20), +0 GTATTTCCCAGAAAAGGAAC (SEQ ID NO:21), +0 AAGCGAAAATGAAATTGACT (SEQ ID NO:22), and +0 CAGGCATAACGGTTCCGTAG (SEQ ID NO:23); (b) at least one antigen; and (c) a pharmaceutically acceptable carrier and/or diluent.